ADAM10 is a multifunctional protease and has been evaluated as a potential therapeutic target and biomarker because of its involvement in the pathogenesis of Alzheimer disease, atherosclerosis, and inflammatory and neoplastic disorders.7, 8, 9, 10, 11. This evidence concerns the gene ADAM10 and early-onset autosomal dominant Alzheimer disease.